EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Three‐dimensional EPI with shot‐selective CAIPIRIHANA for rapid high‐resolution quantitative susceptibility mapping at 3 T

Monique Tourell iD, Jin Jin iD, Beata Bachrata, Ashley Stewart iD, Stefan Ropele, Christian Enzinger, Saskia Bollmann, Steffen Bollmann, Simon Daniel Robinson iD, Kieran O'Brien, Markus Barth iD

Magnetic Resonance in Medicine · 2024

DOI: 10.1002/mrm.30101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2024. Verfasst von Monique Tourell und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Advanced Imaging, University of Queensland, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Imaging, Three-Dimensional, Multiple Sclerosis, Brain, Echo-Planar Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Austrian Federal Ministry for Digital and Economic Affairs, HORIZON EUROPE Marie Sklodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

QSM provides insight into healthy brain aging and neuropathologies such as multiple sclerosis (MS), traumatic brain injuries, brain tumors, and neurodegenerative diseases. Phase data for QSM are usually acquired from 3D gradient‐echo (3D GRE) scans with long acquisition times that are detrimental to patient comfort and susceptible to patient motion. This is particularly true for scans requiring whole‐brain coverage and submillimeter resolutions. In this work, we use a multishot 3D echo plannar imaging (3D EPI) sequence with shot‐selective 2D CAIPIRIHANA to acquire high‐resolution, whole‐brain data for QSM with minimal distortion and blurring.

Methods

To test clinical viability, the 3D EPI sequence was used to image a cohort of MS patients at 1‐mm isotropic resolution at 3 T. Additionally, 3D EPI data of healthy subjects were acquired at 1‐mm, 0.78‐mm, and 0.65‐mm isotropic resolution with varying echo train lengths (ETLs) and compared with a reference 3D GRE acquisition.

Results

The appearance of the susceptibility maps and the susceptibility values for segmented regions of interest were comparable between 3D EPI and 3D GRE acquisitions for both healthy and MS participants. Additionally, all lesions visible in the MS patients on the 3D GRE susceptibility maps were also visible on the 3D EPI susceptibility maps. The interplay among acquisition time, resolution, echo train length, and the effect of distortion on the calculated susceptibility maps was investigated.

Conclusion

We demonstrate that the 3D EPI sequence is capable of rapidly acquiring submillimeter resolutions and providing high‐quality, clinically relevant susceptibility maps.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Imaging, Three-DimensionalMultiple SclerosisBrainEcho-Planar ImagingHumansAdultMaleFemaleAlgorithmsMiddle AgedBrain MappingImage Processing, Computer-AssistedImage Interpretation, Computer-Assisted

Stichwörter der Autor:innen

3D EPICAIPIRINHAQSMhigh resolution

Autor:innen und Institutionen

  • Centre for Advanced Imaging, University of Queensland, Brisbane, Queensland, Australia.
  • ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland, Brisbane, Queensland, Australia.
  • Siemens Healthineers Pty Ltd, Bowen Hills, Queensland, Australia.
  • High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Karl Landsteiner Institute for Clinical Molecular MR in Musculoskeletal Imaging, Vienna, Austria.
  • Department of Medical Engineering, Carinthia University of Applied Sciences, Klagenfurt, Austria.

ORCID-Profile: Monique Tourell, Jin Jin, Ashley Stewart, Simon Daniel Robinson, Markus Barth

Förderung

  • Austrian Science Fund
  • Austrian Federal Ministry for Digital and Economic Affairs
  • HORIZON EUROPE Marie Sklodowska-Curie Actions
  • Österreichische Nationalstiftung für Forschung, Technologie und Entwicklung
  • Australian Research Council

Zitieren

APA

Tourell, M., Jin, J., Bachrata, B., Stewart, A., Ropele, S., Enzinger, C., Bollmann, S., Bollmann, S., Robinson, S. D., O'Brien, K., & Barth, M. (2024). Three‐dimensional EPI with shot‐selective CAIPIRIHANA for rapid high‐resolution quantitative susceptibility mapping at 3 T. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.30101

Vancouver

Tourell M, Jin J, Bachrata B, Stewart A, Ropele S, Enzinger C, et al. Three‐dimensional EPI with shot‐selective CAIPIRIHANA for rapid high‐resolution quantitative susceptibility mapping at 3 T. Magnetic Resonance in Medicine. 2024. doi:10.1002/mrm.30101

BibTeX
@article{Tourell2024,
  author = {Tourell, Monique and Jin, Jin and Bachrata, Beata and Stewart, Ashley and Ropele, Stefan and Enzinger, Christian and Bollmann, Saskia and Bollmann, Steffen and Robinson, Simon Daniel and O'Brien, Kieran and Barth, Markus},
  title = {Three‐dimensional EPI with shot‐selective CAIPIRIHANA for rapid high‐resolution quantitative susceptibility mapping at 3 T},
  journal = {Magnetic Resonance in Medicine},
  year = {2024},
  doi = {10.1002/mrm.30101}
}
Kostenlos starten →